Indications and uses
Helps prevent infection in and temporarily relieves pain due to minor cuts scrapes burns
Helps prevent infection in and temporarily relieves pain due to minor cuts scrapes burns
Adults and children 2 years and older: clean affected area apply a small amount (equal to surface area of tip of finger) on area 1 to 3 times daily may be covered with a sterile bandage Children under 2 years: ask a doctor
(in each gram)
Bacitracin zinc 500 units
Neomycin 3.5 mg
Polymyxin B sulfate 10,000 units
Pramoxine hydrochloride 10 mg
First aid antibiotic/Pain reliever
Helps prevent infection in and temporarily relieves pain due to
For external use only
Allergy alert:
If swallowed, get medical help or contact a Poison Control Center right away.
Adults and children 2 years and older:
Children under 2 years: ask a doctor
White petrolatum
1-800-432-8534 (select option #2) between 9 am and 4 pm EST, Monday-Friday.
Store at 59º - 86ºF (15º - 30ºC).
*Compare to the active ingredients in Neosporin®+ Pain Relief
Preferred plus ++++ Pharmacy
ANTIBIOTIC + PAIN RELIEF
MAXIMUM STRENGTH OINTMENT
BACITRACIN ZINC – NEOMYCIN SULFATE - POLYMYXIN B SULFATE - PRAMOXINE HCl
FIRST AID ANTIBIOTIC /PAIN RELIEVING OINTMENT
NET WT 1 OZ (28 G)
INFECTION PROTECTION
FOR BURNS, CUTS & SCRAPES
Maximum Strength Pain Relief Ointment
08230209A1 VC109276


| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63777-082-31 | 2025-05-22 | C162847 | 48780-1 | 97449f38-cf9b-f6ea-e053-dbdaa90aa703 | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine Hydrochloride |
| 63777-082-31 | 2019-11-13 | C162847 | 48780-1 | 97449f38-cf9b-f6ea-e053-dbdaa90aa703 | Bacitracin Zinc, Neomycin Sulfate, Polymyxin B Sulfate, Pramoxine Hydrochloride |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| BACITRACIN ZINC | ACTIVE INGREDIENT | 89Y4M234ES | 1 | |
| NEOMYCIN SULFATE | ACTIVE INGREDIENT | 057Y626693 | 1 | |
| POLYMYXIN B SULFATE | ACTIVE INGREDIENT | 19371312D4 | 1 | |
| PRAMOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 88AYB867L5 | 1 | |
| BACITRACIN | ACTIVE MOIETY | 58H6RWO52I | 1 | |
| NEOMYCIN | ACTIVE MOIETY | I16QD7X297 | 1 | |
| POLYMYXIN B | ACTIVE MOIETY | J2VZ07J96K | 1 | |
| PRAMOXINE | ACTIVE MOIETY | 068X84E056 | 1 | |
| PETROLATUM | INACTIVE INGREDIENT | 4T6H12BN9U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63777-082 | 63777-082-31 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| BACITRACIN ZINC | 89Y4M234ES | ACTIB |
| NEOMYCIN SULFATE | 057Y626693 | ACTIM |
| POLYMYXIN B SULFATE | 19371312D4 | ACTIB |
| PRAMOXINE HYDROCHLORIDE | 88AYB867L5 | ACTIB |
| PETROLATUM | 4T6H12BN9U | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT, AUGMENTED / TOPICAL | 81.94 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE / VAGINAL | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LOTION / TOPICAL | 25 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM / TOPICAL | 4213 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | OINTMENT / VAGINAL | 4084 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SOAP / TOPICAL | 0.85 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET, EXTENDED RELEASE / ORAL | 0.18 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | CAPSULE, EXTENDED RELEASE / ORAL | 0.07 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | LIQUID / RESPIRATORY (INHALATION) | NA | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| PETROLATUM | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| cb90fe9c-66da-46f5-ba31-954423f0a0dd | f7cc938e-d724-4716-a64d-4d8f93dca09b | 2025-05-14 | Warnings | f7cc938e-d724-4716-a64d-4d8f93dca09b |
Adverse event summaries are temporarily unavailable. Other product information remains available.